Klotho Neurosciences (NASDAQ:KLTO) Shares Down 1.8% – Should You Sell?

Klotho Neurosciences, Inc. (NASDAQ:KLTO) shares fell 1.8% on Thursday . The stock traded as low as $0.27 and last traded at $0.28. 12,690 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 824,509 shares. The stock had previously closed at $0.28.

Klotho Neurosciences Trading Up 6.5 %

The firm has a 50 day simple moving average of $0.36.

Hedge Funds Weigh In On Klotho Neurosciences

An institutional investor recently raised its position in Klotho Neurosciences stock. Geode Capital Management LLC lifted its stake in Klotho Neurosciences, Inc. (NASDAQ:KLTO) by 122.4% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 140,606 shares of the company’s stock after buying an additional 77,372 shares during the quarter. Geode Capital Management LLC owned about 0.52% of Klotho Neurosciences worth $68,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 20.07% of the company’s stock.

About Klotho Neurosciences

Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.